All In MedTech

Device Trial Radar · NCT07479277

Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC

A Multicenter, Randomized, Parallel-Group Trial Evaluating Progel Platinum Added to Mechanical Stapling Versus Mechanical Stapling Alone in Patients Undergoing VATS Upper or Lower Lobectomy for Non-Small Cell Lung Cancer

Last checked: Nov 19, 2026Latest source record: Mar 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Feb 27, 2026

Primary completion

Feb 27, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
Fondazione del Piemonte per l'OncologiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 18, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This multicenter randomized trial evaluates whether routine use of Progel Platinum surgical sealant on stapled fissure lines during VATS upper or lower lobectomy for NSCLC reduces pleural drainage duration compared with standard stapling alone. Secondary objectives include postoperative length of stay, incidence and duration of postoperative air leaks, residual pleural space, safety outcomes, and hospitalization costs.

Conditions

  • Non-Small Cell Lung Cancer
  • Postoperative Air Leak
  • NSCLC

Interventions

  • Progel PlatinumDevice

    Progel Platinum surgical sealant applied to the completed fissure line after stapled fissure completion during VATS upper or lower lobectomy

  • Mechanical StaplingProcedure

    Standard mechanical stapling used for fissure completion during VATS upper or lower lobectomy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Duration of pleural drainageTime frame: From surgery to chest tube removal, assessed up to 30 days after surgery

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Ospedale centrale di Bolzano, Chirurgia Toracica e Vascolare

    Bolzano, Italy · Not yet recruiting

  • Azienda Ospedaliero-Universitaria Careggi

    Florence, Italy · Not yet recruiting

  • Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico

    Milan, Italy · Not yet recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.